Neoplasms. Malignant neoplasms, stated or presumed to be primary, of specified sites, except of lymphoid, haematopoietic and related tissue
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria: Childhood cancer diagnosis; receiving at least one inpatient chemotherapy period; 4 scores in pain (faces pain scale) and fatigue (visual fatigue scale) scales or 3 in anxiety (faces anxiety scale) scale; parents with literature abilities (persian) Exclusion criteria: Any change in chemotherapy protocol; denying participation up to 2 sessions; other medical conditions
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Therapy related symptoms. Timepoint: 1. pretreatment 2. after phase 1 treatment (session 4) 3. after discharge (session 8). Method of measurement: Therapy Related Symptom Checklist (TRSC).;Participation in activity of daily living. Timepoint: 1. pretreatment 2. after phase 1 treatment (session 4) 3. after discharge (session 8). Method of measurement: Iranian Children Participation Questionnaire (ICPQ). | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: pre and post each therapy session. Method of measurement: faces pain scale.;Fatigue. Timepoint: pre and post each therapy session. Method of measurement: visual fatigue scale.;Anxiety. Timepoint: pre and post each therapy session. Method of measurement: faces anxiety scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Iran University of Medical Sciences